World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
50
Citations
7294
World Ranking
4278
National Ranking
1946

John W. Greiner publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where John W. Greiner sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 150 publications — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

John W. Greiner D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where John W. Greiner sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 50 D-Index — 15th percentile

15% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

John W. Greiner is affiliated with the National Institutes of Health in the United States. Their research spans several interconnected fields, primarily focusing on immunology and oncology with multiple contributions to immunotherapy and immune response studies.

Their recent publications include the following works:

  • The Development of Next-generation PBMC Humanized Mice for Preclinical Investigation of Cancer Immunotherapeutic Agents, 2020, Anticancer Research
  • NHS-IL12, a Tumor-Targeting Immunocytokine, 2021, ImmunoTargets and Therapy
  • The Use of a Humanized NSG-β2m−/− Model for Investigation of Immune and Anti-tumor Effects Mediated by the Bifunctional Immunotherapeutic Bintrafusp Alfa, 2020, Frontiers in Oncology
  • Aging modulates the immunosuppressive, polarizing and metabolic functions of blood-derived myeloid-derived suppressor cells (MDSCs), 2025, Immunity & Ageing
  • 1136 Vaccine targeting of the tumor-associated antigen brachyury reduces development of colitis-induced colorectal lesions in the APCMin/+mouse model, 2023, Regular and Young Investigator Award Abstracts

The research topics covered in these papers reflect a focus on the following areas:

  • CAR-T cell therapy research
  • Immunotherapy and Immune Responses
  • Immune Cell Function and Interaction
  • Cancer Immunotherapy and Biomarkers
  • Virus-based gene therapy research
  • Immune cells in cancer
  • Immune Response and Inflammation

John W. Greiner's work predominantly falls within immunology and microbiology, with notable contributions to medicine. Their research is further detailed by involvement in subfields such as immunology, oncology, genetics, pathology and forensic medicine, and biotechnology.

The scientist has collaborated frequently with several co-authors, including Jeffrey Schlom, Y. Maurice Morillon, Ariana Sabzevari, Lucas A. Horn, and Claudia Palena. These collaborations have contributed to a breadth of published research across multiple venues.

Publication venues where John W. Greiner's work has appeared include:

  • Anticancer Research
  • ImmunoTargets and Therapy
  • Frontiers in Oncology
  • Immunity & Ageing
  • Regular and Young Investigator Award Abstracts

Best Publications

  • Chitosan solution enhances both humoral and cell-mediated immune responses to subcutaneous vaccination.

    David A. Zaharoff;Connie J. Rogers;Kenneth W. Hance;Jeffrey Schlom

  • Generation and Characterization of B72.3 Second Generation Monoclonal Antibodies Reactive with the Tumor-associated Glycoprotein 72 Antigen

    R Muraro;M Kuroki;D Wunderlich;D J Poole

  • Enhanced expression of surface tumor-associated antigens on human breast and colon tumor cells after recombinant human leukocyte α-interferon treatment

    John W. Greiner;Patricia Horan Hand;Philip Noguchi;Paul B. Fisher

  • Recombinant interferon enhances monoclonal antibody-targeting of carcinoma lesions in vivo

    John W. Greiner;Fiorella Guadagni;Philip Noguchi;Sidney Pestka

  • Physical activity and cancer prevention : pathways and targets for intervention.

    Connie J. Rogers;Lisa H. Colbert;John W. Greiner;Susan N. Perkins

  • Induction of Protective Host Immunity to Carcinoembryonic Antigen (CEA), a Self-Antigen in CEA Transgenic Mice, by Immunizing with a Recombinant Vaccinia-CEA Virus

    Erik Kass;Jeffrey Schlom;John Thompson;Fiorella Guadagni

  • An NK cell line (haNK) expressing high levels of granzyme and engineered to express the high affinity CD16 allele.

    Caroline Jochems;James W. Hodge;Massimo Fantini;Rika Fujii

  • The immunocytokine NHS-IL12 as a potential cancer therapeutic

    Jonathan Fallon;Robert Tighe;Giorgio Kradjian;Wilson Guzman

  • Granulocyte/macrophage-colony stimulating factor produced by recombinant avian poxviruses enriches the regional lymph nodes with antigen-presenting cells and acts as an immunoadjuvant

    Erik Kass;Dennis L. Panicali;Gail Mazzara;Jeffrey Schlom

  • Vaccine-based therapy directed against carcinoembryonic antigen demonstrates antitumor activity on spontaneous intestinal tumors in the absence of autoimmunity.

    John W Greiner;Hasan Zeytin;Miriam R Anver;Jeffrey Schlom

  • Immunogenicity and safety of a recombinant vaccinia virus vaccine expressing the carcinoembryonic antigen gene in a nonhuman primate.

    J. Kantor;K. Irvine;S. Abrams;P. Snoy

  • Intravesical Immunotherapy of Superficial Bladder Cancer with Chitosan/Interleukin-12

    David A. Zaharoff;Benjamin S. Hoffman;H. Brooks Hooper;Compton J. Benjamin

  • Regulation of Carcinoembryonic Antigen Expression in Different Human Colorectal Tumor Cells by Interferon-γ

    Fiorella Guadagni;Patricia L. Witt;Paul F. Robbins;Jeffrey Schlom

  • Vaccination with a recombinant Saccharomyces cerevisiae expressing a tumor antigen breaks immune tolerance and elicits therapeutic antitumor responses.

    Elizabeth K. Wansley;Mala Chakraborty;Kenneth W. Hance;Michael B. Bernstein

  • Intratumoral immunotherapy of established solid tumors with chitosan/IL-12.

    David A. Zaharoff;Kenneth W. Hance;Connie J. Rogers;Jeffrey Schlom

  • Selective Interferon-Induced Enhancement of Tumor-Associated Antigens on a Spectrum of Freshly Isolated Human Adenocarcinoma Cells

    Fiorella Guadagni;Jeffrey Schlom;William W. Johnston;Cheryl A. Szpak

  • Systemic Immunotherapy of Non-Muscle Invasive Mouse Bladder Cancer with Avelumab, an Anti–PD-L1 Immune Checkpoint Inhibitor

    Amanda J. Vandeveer;Jonathan K. Fallon;Robert Tighe;Helen Sabzevari

  • Improved Immunotherapy of a Recombinant Carcinoembryonic Antigen Vaccinia Vaccine When Given in Combination with Interleukin-2

    Joanne P. McLaughlin;Jeffrey Schlom;Judy A. Kantor;John W. Greiner

  • CA 72-4 measurement of tumor-associated glycoprotein 72 (TAG-72) as a serum marker in the management of gastric carcinoma

    Fiorella Guadagni;Mario Roselli;Teresa Amato;Maurizio Cosimelli

  • Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA : Longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers

    Fiorella Guadagni;Judith Kantor;Simona Aloe;Maria Daniela Carone

Frequent Co-Authors

Jeffrey Schlom
Jeffrey Schlom National Institutes of Health
Stephen D. Hursting
Stephen D. Hursting University of North Carolina at Chapel Hill
James W. Hodge
James W. Hodge National Institutes of Health
Kwong Y. Tsang
Kwong Y. Tsang National Institutes of Health
Sidney Pestka
Sidney Pestka Rutgers, The State University of New Jersey
James L. Gulley
James L. Gulley National Institutes of Health
Paul B. Fisher
Paul B. Fisher Virginia Commonwealth University
Ernest C. Borden
Ernest C. Borden Cleveland Clinic
Philip M. Arlen
Philip M. Arlen National Institutes of Health
David Goldstein
David Goldstein University of New South Wales

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, expanding your expertise through specialized online programs can open diverse career opportunities. Many professionals pursue healthcare-related degrees to complement their scientific background and enhance clinical skills.

One popular path is advancing into nurse practitioner roles. Students may explore affordable pmhnp programs to enter psychiatric mental health nursing, which integrates biological and psychological knowledge essential for holistic patient care.

When considering salary expectations, understanding the dnp salary by location is crucial for planning your career growth and making informed decisions about further education or specialization.

Many nurse practitioners aim to expand their scope by obtaining certifications such as the fnp to acute care certification. This transition enhances the ability to manage complex acute conditions, often intersecting with immunological disorders.

For faster entry into these fields, consider enrolling in a nurse practitioner accelerated program, designed to help qualified candidates quickly advance their careers in healthcare without sacrificing quality or depth of knowledge.

Best Scientists Citing John W. Greiner

Trending Scientists

Recently Published Articles